Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synthesis is a broad biological term describing the fundamental process of creating complex organic molecules from simpler precursors, a category of reactions collectively known as anabolism (Alberts et al., 2014; NIH, 2023). This includes vital cellular activities such as DNA replication, RNA transcription, and protein translation, which are essential for life, cell growth, and repair (Britannica, 2024). In the context of drug discovery, 'synthesis' is not recognized as a specific therapeutic target molecule like a receptor, transporter, or enzyme; instead, drugs are designed to interact with the specific proteins and macromolecular complexes that facilitate these processes, such as the ribosome, DNA polymerase, or specific synthases (PubMed, 2022). Because 'synthesis' describes a functional metabolic outcome rather than a discrete physical structure with a defined binding site or unique genetic locus, it cannot be classified as a target for pharmacological intervention or clinical patient selection.
Not applicable; synthesis is a general biological process rather than a discrete molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synthesis.